Participants 71 124 6
patients with human immunodeficiency virus infection.
Participants 571 717 8
12 HIV-infected patients (mean [+/- standard deviation] CD4+ cell count, 304 +/- 213/mm3) were enrolled in a three-way crossover single-dose study
